Nanrilkefusp alfa

DB17480Investigational

Nanrilkefusp alfa is a human fusion protein consisting of the cytokine interleukin (IL)-15 and the high-affinity binding sushi+ domain of IL-15 receptor alpha (IL-15Ra).

Mechanism: Pharmacologically active on Interleukin-2 receptor subunit beta and Cytokine receptor common subunit gamma
Curator reviewed
Code names: RLI-15 · SO-C101 · SOT101

Resolves to

Compound

UNIIUM4VY7ZEC9

Targets

P14784IL2RBP31785IL2RG

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Nanrilkefusp alfa, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account